Anti-Human Abeta Therapeutic Antibody (Crenezumab)
Recombinant monoclonal antibody to Abeta. Crenezumab is a humanized monoclonal antibody against human 1-40 and 1-42 Beta amyloid, which is being investigated as a treatment of Alzheimer's disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-226 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | Abeta |
| Species Reactivity | Human |
| Type | IgG4 - kappa |
| Applications | Suitable for use in WB, IF, IP, Neut, FuncS, ELISA, FC and most other immunological methods. |
| Storage | At -20°C for one year. |